107 related articles for article (PubMed ID: 2536588)
1. Humoral hypercalcemia in Hodgkin's disease. Clinical and laboratory evaluation.
Jacobson JO; Bringhurst FR; Harris NL; Weitzman SA; Aisenberg AC
Cancer; 1989 Mar; 63(5):917-23. PubMed ID: 2536588
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia and vitamin D metabolism in Hodgkin's disease. Is there an underlying immunoregulatory relationship?
Rieke JW; Donaldson SS; Horning SJ
Cancer; 1989 May; 63(9):1700-7. PubMed ID: 2649225
[TBL] [Abstract][Full Text] [Related]
3. Humoral hypercalcemia in Hodgkin's disease. Association with elevated 1,25-dihydroxycholecalciferol levels and subperiosteal bone resorption.
Zaloga GP; Eil C; Medbery CA
Arch Intern Med; 1985 Jan; 145(1):155-7. PubMed ID: 3838228
[TBL] [Abstract][Full Text] [Related]
4. Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia.
Shigeno C; Yamamoto I; Dokoh S; Hino M; Aoki J; Yamada K; Morita R; Kameyama M; Torizuka K
J Clin Endocrinol Metab; 1985 Oct; 61(4):761-8. PubMed ID: 2993347
[TBL] [Abstract][Full Text] [Related]
5. Abnormal vitamin D metabolism in Hodgkin's lymphoma.
Davies M; Mawer EB; Hayes ME; Lumb GA
Lancet; 1985 May; 1(8439):1186-8. PubMed ID: 2860388
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcaemia in Hodgkin's disease related to prostaglandin synthesis.
Laforga JB; Vierna J; Aranda FI
J Clin Pathol; 1994 Jun; 47(6):567-8. PubMed ID: 8063947
[TBL] [Abstract][Full Text] [Related]
7. Recurrent hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in Hodgkin's disease.
Mercier RJ; Thompson JM; Harman GS; Messerschmidt GL
Am J Med; 1988 Jan; 84(1):165-8. PubMed ID: 3337120
[TBL] [Abstract][Full Text] [Related]
8. Humoral Hypercalcemia in Uterine Cancers: A Case Report and Literature Review.
Motilal Nehru V; Garcia G; Ding J; Kong F; Dai Q
Am J Case Rep; 2017 Jan; 18():22-25. PubMed ID: 28057913
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone related protein in hypercalcaemia of Hodgkin's disease.
Bolo-Deoku J; Basu S; Lakhani S; Dunne F; Ratcliffe WA; Clarke M; Barron JL
J Clin Pathol; 1992 Jun; 45(6):541-2. PubMed ID: 1624608
[TBL] [Abstract][Full Text] [Related]
10. Intermittent hypercalcaemia and vitamin D sensitivity in Hodgkin's disease.
Karmali R; Barker S; Hewison M; Fraher L; Katz DR; O'Riordan JL
Postgrad Med J; 1990 Sep; 66(779):757-60. PubMed ID: 2235811
[TBL] [Abstract][Full Text] [Related]
11. Ectopic hyperparathyroidism with renal calculi and subperiosteal bone resorption. Report of case.
Scholz DA; Riggs BL; Purnell DC; Goldsmith RS; Arnaud CD
Mayo Clin Proc; 1973 Feb; 48(2):124-6. PubMed ID: 4689657
[No Abstract] [Full Text] [Related]
12. Parathyroid-hormone-related-protein-associated hypercalcemia in a patient with CLL-type low-grade leukemic B-cell lymphoma.
Schöttker B; Heinz W; Weissinger F; Sözener K; Eck M; Seufert J
Haematologica; 2006 Dec; 91(12 Suppl):ECR45. PubMed ID: 17194651
[TBL] [Abstract][Full Text] [Related]
13. Suppression of serum 1,25-dihydroxyvitamin D in humoral hypercalcemia of malignancy is caused by elaboration of a factor that inhibits renal 1,25-dihydroxyvitamin D3 production.
Fukumoto S; Matsumoto T; Yamoto H; Kawashima H; Ueyama Y; Tamaoki N; Ogata E
Endocrinology; 1989 May; 124(5):2057-62. PubMed ID: 2539966
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
[TBL] [Abstract][Full Text] [Related]
15. Humoral hypercalcemia of malignancy.
Burtis WJ; Wu TL; Insogna KL; Stewart AF
Ann Intern Med; 1988 Mar; 108(3):454-7. PubMed ID: 3277518
[No Abstract] [Full Text] [Related]
16. [Paraneoplastic hypercalcemia].
Elomaa I
Duodecim; 1978; 94(22):1390-6. PubMed ID: 720245
[No Abstract] [Full Text] [Related]
17. Hypercalcemia due to vitamin D-secreting hodgkin's lymphoma exacerbated by oral calcium supplementation.
Gupta R; Neal JM
Endocr Pract; 2006; 12(2):227-9. PubMed ID: 16690471
[No Abstract] [Full Text] [Related]
18. Hypercalcemia in Hodgkin's disease.
Eldar M; Shoenfeld Y; Douer D; Pinkhas J
Haematologica; 1980 Aug; 65(4):459-63. PubMed ID: 6774917
[No Abstract] [Full Text] [Related]
19. Interplay of parathyroid hormone-related peptide (PTHrP), renal insufficiency and bulky disease in the pathogenesis of hypercalcemia in Hodgkin's lymphoma (HL).
Chevalier N; Udi J; Sigler M; Wolf ME; Heinz J; Schmitt-Graeff A; Seufert J; Wäsch R; Engelhardt M
Eur J Haematol; 2010 Oct; 85(4):368-9. PubMed ID: 20561035
[No Abstract] [Full Text] [Related]
20. Bone resorption and humoral hypercalcemia of malignancy: stimulation of bone resorption in vitro by tumor extracts is inhibited by prostaglandin synthesis inhibitors.
Minkin C; Fredericks RS; Pokress S; Rude RK; Sharp CF; Tong M; Singer FR
J Clin Endocrinol Metab; 1981 Nov; 53(5):941-7. PubMed ID: 6793615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
